PDF icon PDF herunterladen
Open Access
CC BY 4.0 · Glob Med Genet 2022; 09(02): 063-071
DOI: 10.1055/s-0041-1741109
Review Article

Determinants in Tailoring Antidiabetic Therapies: A Personalized Approach

Aliya A. Rizvi
1   Department of Personalized and Molecular Medicine, Era University, Lucknow, Uttar Pradesh, India
,
Mohammad Abbas
1   Department of Personalized and Molecular Medicine, Era University, Lucknow, Uttar Pradesh, India
,
Sushma Verma
1   Department of Personalized and Molecular Medicine, Era University, Lucknow, Uttar Pradesh, India
,
Shrikant Verma
1   Department of Personalized and Molecular Medicine, Era University, Lucknow, Uttar Pradesh, India
,
Almas Khan
1   Department of Personalized and Molecular Medicine, Era University, Lucknow, Uttar Pradesh, India
,
Syed T. Raza
2   Department of Biochemistry, Era University, Lucknow Medical College and Hospital, Lucknow, Uttar Pradesh, India
,
Farzana Mahdi
1   Department of Personalized and Molecular Medicine, Era University, Lucknow, Uttar Pradesh, India
› Institutsangaben
Funding The work was supported by intramural funding of Era University, Lucknow, India.
› Weitere Informationen
Auch verfügbar aufeRef
  Lizenzen und Reprints
Preview

Abstract

Diabetes has become a pandemic as the number of diabetic people continues to rise globally. Being a heterogeneous disease, it has different manifestations and associated complications in different individuals like diabetic nephropathy, neuropathy, retinopathy, and others. With the advent of science and technology, this era desperately requires increasing the pace of embracing precision medicine and tailoring of drug treatment based on the genetic composition of individuals. It has been previously established that response to antidiabetic drugs, like biguanides, sulfonylureas, dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide 1 (GLP-1) agonists, and others, depending on variations in their transporter genes, metabolizing genes, genes involved in their action, etc. Responsiveness of these drugs also relies on epigenetic factors, including histone modifications, miRNAs, and DNA methylation, as well as environmental factors and the lifestyle of an individual. For precision medicine to make its way into clinical procedures and come into execution, all these factors must be reckoned with. This review provides an insight into several factors oscillating around the idea of precision medicine in type-2 diabetes mellitus.

Keywords

diabetes - precision medicine - pharmacogenomics - drug response


Publikationsverlauf

Eingereicht: 08. November 2021

Angenommen: 20. November 2021

Artikel online veröffentlicht:
21. Januar 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany